DYNE THERAPEUTICS INC (DYN)
NASDAQ • Healthcare
$26
-$0.14 (-0.6%)
Market open
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About DYNE THERAPEUTICS INC
Name
DYNE THERAPEUTICS INC
CEO
John G. Cox
Website
Industry
Healthcare
Year Founded
2017
Employees
289
Dyne Therapeutics, Inc. is a NASDAQ-listed biotechnology company developing therapeutics for muscle disease. The company focuses on genetically driven disorders and operates as a small-cap healthcare developer, with its programs centered on disease-modifying approaches for serious rare conditions rather than commercialized products.
Fundamentals & Financials
Revenue (TTM)
$0
Net Income (TTM)
-$519.4M
EPS (TTM)
-$3.33
ROA (TTM)
-52.25%
Current Ratio
12.02
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Stay Ahead of the Market
Get premium market insights delivered directly to your inbox.
Quote Summary
Previous CloseDay Range$26$25.46 - $26.31
52 Week RangeAvg. Volume$11.65 - $27.312.6M
Market Cap$4.8B
Peers & Related Assets
APGEAPOGEE THERAPEUTICS INC
$134.57-0.0%
CGONCG ONCOLOGY INC
$76.29-1.1%
MIRMMIRUM PHARMACEUTICALS INC
$100.87+1.0%
XENEXENON PHARMACEUTICALS INC
$63.18+1.3%
CELCCELCUITY INC
$93.24+0.9%
RAREULTRAGENYX PHARMACEUTICAL INC
$25.49-2.5%
CNTACentessa Pharmaceuticals plc
TLXTelix Pharmaceuticals Limited
AAPGAscentage Pharma Group International
SLNOSOLENO THERAPEUTICS INC